SmartMeds, Air2Web partner on interactive appsSmartMeds.com, a subsidiary of Infu-Tech, has closed an agreement with Air2Web to develop applications for HMOs, physicians, and patients using Air2Web's wireless Internet platform. The companies
SmartMeds, Air2Web partner on interactive apps
SmartMeds.com, a subsidiary of Infu-Tech, has closed an agreement with Air2Web to develop applications for HMOs, physicians, and patients using Air2Web's wireless Internet platform. The companies are creating software that will enable customers using two-way wireless text messaging or Web-enabled cell phones to get health news, information, and services, including prescription refills. The firms are launching a pilot program with 1500 members of New York City-based HMO Care Plus.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.